The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Biomarkers of Inflammation in Inflammatory Bowel Disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Rutgeerts, P., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050516 · Cited by 3,902
Self-citationLaboratory markers in IBD: useful, magic, or unnecessary toys?
Vermeire, S., Van Assche, G., & Rutgeerts, P. (2006) · Gut · doi:10.1136/gut.2005.069476 · Cited by 952
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
DʼHaens, G., Ferrante, M., Vermeire, S., Baert, F., Noman, M., Moortgat, L., Geens, P., Iwens, D., Aerden, I., Van Assche, G., et al. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22917 · Cited by 816
Predicting outcome in severe ulcerative colitis.
Travis, S. P., Farrant, J. M., Ricketts, C., Nolan, D. J., Mortensen, N. M., Kettlewell, M. G., & Jewell, D. P. (1996) · Gut · doi:10.1136/gut.38.6.905 · Cited by 788
Sands, B. E., Feagan, B. G., Rutgeerts, P., Colombel, J.-F., Sandborn, W. J., Sy, R., D’Haens, G., Ben-Horin, S., Xu, J., Rosario, M., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.05.008 · Cited by 715
Self-citationvan Rheenen, P. F., Van de Vijver, E., & Fidler, V. (2010) · BMJ · doi:10.1136/bmj.c3369 · Cited by 714
Rapid and Noninvasive Metabonomic Characterization of Inflammatory Bowel Disease
Marchesi, J. R., Holmes, E., Khan, F., Kochhar, S., Scanlan, P., Shanahan, F., Wilson, I. D., & Wang, Y. (2007) · Journal of Proteome Research · doi:10.1021/pr060470d · Cited by 631
Crohn's disease management after intestinal resection: a randomised trial
De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, E. O., Gorelik, A., Liew, D., Prideaux, L., Lawrance, I. C., Andrews, J. M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61908-5 · Cited by 619
Natalizumab for the Treatment of Active Crohn’s Disease: Results of the ENCORE Trial
Targan, S. R., Feagan, B. G., Fedorak, R. N., Lashner, B. A., Panaccione, R., Present, D. H., Spehlmann, M. E., Rutgeerts, P. J., Tulassay, Z., Volfova, M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.024 · Cited by 614
Schoepfer, A. M., Beglinger, C., Straumann, A., Trummler, M., Vavricka, S. R., Bruegger, L. E., & Seibold, F. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.545 · Cited by 570
Costa, F., Mumolo, M. G., Ceccarelli, L., Bellini, M., Romano, M. R., Sterpi, C., Ricchiuti, A., Marchi, S., & Bottai, M. (2005) · Gut · doi:10.1136/gut.2004.043406 · Cited by 550
C-Reactive Protein as a Marker for Inflammatory Bowel Disease
Vermeire, S., Van Assche, G., & Rutgeerts, P. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200409000-00026 · Cited by 513
Peyrin-Biroulet, L., Reinisch, W., Colombel, J.-F., Mantzaris, G. J., Kornbluth, A., Diamond, R., Rutgeerts, P., Tang, L. K., Cornillie, F. J., & Sandborn, W. J. (2014) · Gut · doi:10.1136/gutjnl-2013-304984 · Cited by 502
Sipponen, T., Savilahti, E., Kolho, K.-L., Nuutinen, H., Turunen, U., & Färkkilä, M. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20312 · Cited by 480
Jones, J., Loftus, E. V., Panaccione, R., Chen, L., Peterson, S., Mcconnell, J., Baudhuin, L., Hanson, K., Feagan, B. G., Harmsen, S. W., et al. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.06.010 · Cited by 414
Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s Disease
Monteleone, G., Neurath, M. F., Ardizzone, S., Di Sabatino, A., Fantini, M. C., Castiglione, F., Scribano, M. L., Armuzzi, A., Caprioli, F., Sturniolo, G. C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1407250 · Cited by 401
Menees, S. B., Powell, C., Kurlander, J., Goel, A., & Chey, W. D. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.6 · Cited by 391
Cornillie, F., Hanauer, S. B., Diamond, R. H., Wang, J., Tang, K. L., Xu, Z., Rutgeerts, P., & Vermeire, S. (2014) · Gut · doi:10.1136/gutjnl-2012-304094 · Cited by 374
Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse
Gisbert, J. P., Bermejo, F., Pérez-Calle, J.-L., Taxonera, C., Vera, I., McNicholl, A. G., Algaba, A., López, P., López-Palacios, N., Calvo, M., et al. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20933 · Cited by 315
Schoepfer, A. M., Beglinger, C., Straumann, A., Safroneeva, E., Romero, Y., Armstrong, D., Schmidt, C., Trummler, M., Pittet, V., & Vavricka, S. R. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e3182810066 · Cited by 294
Mao, R., Xiao, Y.-L., Gao, X., Chen, B.-L., He, Y., Yang, L., Hu, P.-J., & Chen, M.-H. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22861 · Cited by 280
Wright, E. K., Kamm, M. A., De Cruz, P., Hamilton, A. L., Ritchie, K. J., Krejany, E. O., Leach, S., Gorelik, A., Liew, D., Prideaux, L., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.01.026 · Cited by 280
Peyrin-Biroulet, L., Gonzalez, F., Dubuquoy, L., Rousseaux, C., Dubuquoy, C., Decourcelle, C., Saudemont, A., Tachon, M., Béclin, E., Odou, M.-F., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300370 · Cited by 274
Henderson, P., Anderson, N. H., & Wilson, D. C. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.131 · Cited by 234
Peripheral blood MicroRNAs distinguish active ulcerative colitis and Crohnʼs disease
Wu, F., Guo, N. J., Tian, H., Marohn, M., Gearhart, S., Bayless, T. M., Brant, S. R., & Kwon, J. H. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21450 · Cited by 231
Foell, D., Wittkowski, H., & Roth, J. (2009) · Gut · doi:10.1136/gut.2008.170019 · Cited by 217
Lasson, A., Stotzer, P.-O., Öhman, L., Isaksson, S., Sapnara, M., & Strid, H. (2014) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2014.06.002 · Cited by 211
Can Calprotectin Predict Relapse Risk in Inflammatory Bowel Disease?
D'Incà, R., Dal Pont, E., Di Leo, V., Benazzato, L., Martinato, M., Lamboglia, F., Oliva, L., & Carlo Sturniolo, G. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01870.x · Cited by 211
Samuel, S., Bruining, D. H., Loftus, E. V., Becker, B., Fletcher, J. G., Mandrekar, J. N., Zinsmeister, A. R., & Sandborn, W. J. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.03.026 · Cited by 206
Vos, M. D., Louis, E. J., Jahnsen, J., Vandervoort, J. G. P., Noman, M., Dewit, O., DʼHaens, G. R., Franchimont, D., Baert, F. J., Torp, R. A., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31829b2a37 · Cited by 202
The role and utility of faecal markers in inflammatory bowel disease
Lehmann, F. S., Burri, E., & Beglinger, C. (2014) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x14553384 · Cited by 178
Lobatón, T., López‐García, A., Rodríguez‐Moranta, F., Ruiz, A., Rodríguez, L., & Guardiola, J. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.05.005 · Cited by 170
Circulating MicroRNA Is a Biomarker of Pediatric Crohn Disease
Zahm, A. M., Thayu, M., Hand, N. J., Horner, A., Leonard, M. B., & Friedman, J. R. (2011) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31822200cc · Cited by 165
Bjerrum, J. T., Nielsen, O. H., Hao, F., Tang, H., Nicholson, J. K., Wang, Y., & Olsen, J. (2009) · Journal of Proteome Research · doi:10.1021/pr9008223 · Cited by 165
Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
García-Sánchez, V., Iglesias-Flores, E., González, R., Gisbert, J. P., Gallardo-Valverde, J. M., González-Galilea, Á., Naranjo-Rodríguez, A., de Dios-Vega, J. F., Muntané, J., & Gómez-Camacho, F. (2010) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2009.09.008 · Cited by 163
Serum Analysis of Tryptophan Catabolism Pathway: Correlation With Crohnʼs Disease Activity
Gupta, N., Thaker, A. I., Kanuri, N. D., Riehl, T. E., Rowley, C. W., Stenson, W. F., & Ciorba, M. A. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21849 · Cited by 159
Sipponen, T. M., af Björkesten, C.-G., Färkkilä, M. A., Nuutinen, H. U., Savilahti, E., & Kolho, K. (2009) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365520903483650 · Cited by 155
Laboratory markers in ulcerative colitis: Current insights and future advances
Cioffi, M., Rosa, A. D., Serao, R., Picone, I., & Vietri, M. T. (2015) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v6.i1.13 · Cited by 152
Serum calprotectin as a biomarker for Crohn's disease
Meuwis, M., Vernier‐Massouille, G., Grimaud, J., Bouhnik, Y., Laharie, D., Piver, É., Seidel, L., Colombel, J., & Louis, E. J. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.06.008 · Cited by 150
Kolho, K., Raivio, T., Lindahl, H. G., & Savilahti, E. (2006) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520500419623 · Cited by 146
Regueiro, M. D., Kip, K. E., Schraut, W. H., Baidoo, L., Sepulveda, A. R., Pesci, M., El‐Hachem, S., Harrison, J., & Binion, D. G. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21355 · Cited by 146
Biological markers in inflammatory bowel disease: Practical consideration for clinicians
Mendoza, J. L., & Abreu, M. T. (2009) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(09)73151-3 · Cited by 146
Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease
Lamb, C. A., Mohiuddin, M. K., Gicquel, J., Neely, D., Bergin, F. G., Hanson, J. M., & Mansfield, J. C. (2009) · British journal of surgery · doi:10.1002/bjs.6593 · Cited by 142
Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease
Walkiewicz, D., Werlin, S. L., Fish, D. L., Scanlon, M. C., Hanaway, P. J., & Kugathasan, S. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20376 · Cited by 142
Vos, M. D., Dewit, O., D’Haens, G., Baert, F., Fontaine, F., Vermeire, S., Franchimont, D. P., Moreels, T. G., Staessen, D., Terriere, L., et al. (2011) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2011.11.002 · Cited by 141
Boschetti, G., Laidet, M., Moussata, D., Stéfanescu, C., Roblin, X., Phelip, G., Cotte, E., Passot, G., François, Y., Drai, J., et al. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.30 · Cited by 136
Guardiola, J., Lobatón, T., Alonso, L. R., Ruiz‐Cerulla, A., Aràjol, C., Loayza, C., Sanjuán, X., Sánchez, E., & Rodríguez‐Moranta, F. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.06.020 · Cited by 135
Kallel, L., Ayadi, I., Matri, S., Fekih, M., Mahmoud, N. B., Feki, M., Karoui, S., Zouari, B., Boubaker, J., Kaabachi, N., et al. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832bab49 · Cited by 124
Orlando, A., Modesto, I., Castiglione, F., Scala, L., Scimeca, D., Rispo, A., Teresi, S., Mocciaro, F., Criscuoli, V. V., Marrone, C., et al. (2006) · PubMed · Cited by 120
Patel, P., Križ, J., Gravel, M., Soucy, G., Bareil, C., Gravel, C., & Julien, J. (2014) · Molecular Therapy · doi:10.1038/mt.2013.239 · Cited by 114
Faubion, W. A., Fletcher, J. G., O’Byrne, S., Feagan, B. G., de Villiers, W. J. S., Salzberg, B. A., Plevy, S. E., Proctor, D. D., Valentine, J. F., Higgins, P., et al. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.354 · Cited by 113
Fecal Lactoferrin and Calprotectin After Ileocolonic Resection for Crohn's Disease
Scarpa, M., Renata D'Incà, Basso, D., Ruffolo, C., Polese, L., Bertin, E., Luise, A., Frego, M., Plebani, M., Sturniolo, G. C., et al. (2007) · Diseases of the Colon & Rectum · doi:10.1007/s10350-007-0225-6 · Cited by 103
Coskun, M., Bjerrum, J. T., Seidelin, J. B., Troelsen, J. T., Olsen, J., & Nielsen, O. H. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i27.4289 · Cited by 96
Mesalamine Dose Escalation Reduces Fecal Calprotectin in Patients With Quiescent Ulcerative Colitis
Osterman, M. T., Aberra, F. N., Cross, R. K., Liakos, S., McCabe, R. P., Shafran, I., Wolf, D. C., Hardi, R., Nessel, L. A., Brensinger, C. M., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.03.035 · Cited by 96
Faecal calprotectin in children with clinically quiescent inflammatory bowel disease
Sipponen, T. M., & Kolho, K. (2010) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521003782389 · Cited by 93
Patel, N., Alkhouri, N., Eng, K., Cikach, F. S., Mahajan, L. A., Yan, C., Grove, D., Rome, E. S., López, R., & Dweik, R. A. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12861 · Cited by 91
Fecal M2-pyruvate kinase (M2-PK): A novel marker of intestinal inflammation
Chung‐Faye, G., Hayee, B., Maestranzi, S., Donaldson, N., Forgács, I., & Sherwood, R. A. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20214 · Cited by 89
Johnson, J. C., Schmidt, C. R., Shrubsole, M. J., Billheimer, D. D., Joshi, P., Morrow, J. D., Heslin, M. J., Washington, M. K., Ness, R. M., Zheng, W., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.07.015 · Cited by 87
Diamanti, A., Colistro, F., Basso, M. S., Papadatou, B., Francalanci, P., Bracci, F., Muraca, M., Knafelz, D., Angelis, P. D., & Castro, M. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20472 · Cited by 79
Yamamoto, T., Shiraki, M., Bamba, T., Umegae, S., & Matsumoto, K. (2013) · International Journal of Colorectal Disease · doi:10.1007/s00384-013-1817-3 · Cited by 77
Arai, Y., Arihiro, S., Matsuura, T., Kato, T., Matsuoka, M., Saruta, M., Mitsunaga, M., Matsuura, M., Fujiwara, M., Okayasu, I., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000062 · Cited by 72
Meuwis, M., Fillet, M., Lutteri, L., Marée, R., Geurts, P., de Seny, D., Malaise, M., Chapelle, J.-P., Wehenkel, L. A., Bélaïche, J., et al. (2008) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2008.04.021 · Cited by 69
Lasson, A., Simrén, M., Stotzer, P., Isaksson, S., Öhman, L., & Strid, H. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31827e78be · Cited by 65
Storr, M., Vogel, H. J., & Schicho, R. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328361f488 · Cited by 60
Urinary leukotriene E4 excretion: A biomarker of inflammatory bowel disease activity
Stanke‐Labesque, F., Pofelski, J., Moreau–Gaudry, A., Bessard, G., & Bonaz, B. L. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20403 · Cited by 59
Aomatsu, T., Imaeda, H., Matsumoto, K., Kimura, E., Yoden, A., Tamai, H., Fujiyama, Y., Mizoguchi, E., & Andoh, A. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04805.x · Cited by 58
Poulsen, N. A., Andersen, V. C., Møller, J. C., Møller, H. S., Jessen, F., Purup, S., & Larsen, L. B. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-76 · Cited by 54
Bolignano, D., Torre, A. D., Lacquaniti, A., Costantino, G., Fries, W., & Buemi, M. (2010) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3181ccc20c · Cited by 50
Increased urinary F2-isoprostanes in patients with Crohn's disease
Cracowski, J., Bonaz, B. L., Bessard, G., Bessard, J., Anglade, C., & Fournet, J. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05427.x · Cited by 50
Genetic determinants of C-reactive protein
Danik, J. S., & Ridker, P. M. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0019-2 · Cited by 48
Rubin, D. T., Mulani, P. M., Chao, J., Pollack, P. F., Bensimon, A. G., Yu, A. P., & Ghosh, S. K. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21836 · Cited by 34
Kohashi, M., Nishiumi, S., Ooi, M., Yoshie, T., Matsubara, A., Suzuki, M., Hoshi, N., Kamikozuru, K., Yokoyama, Y., Fukunaga, K., et al. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.01.024 · Cited by 34
Önal, İ. K., Beyazıt, Y., Şener, B., SAVUK, B., Etik, D. Ö., Sayılır, A., Öztaş, E., Torun, S., Özın, Y., Demirel, B., et al. (2012) · The Turkish Journal of Gastroenterology · doi:10.4318/tjg.2012.0421 · Cited by 33
Blood-based Biomarkers Used to Predict Disease Activity in Crohnʼs Disease and Ulcerative Colitis
Burakoff, R. B., Pabby, V., Onyewadume, L., Odze, R. D., Adackapara, C., Wang, W., Friedman, S., Hamilton, M., Korzenik, J. R., LEVINE, J. S., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000340 · Cited by 32
Patel, N. R., McPhail, M. J. W., Shariff, M. I. F., Keun, H. C., & Taylor-Robinson, S. D. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.12.1 · Cited by 30
Quantitative proteomic approaches in biomarker discovery of inflammatory bowel disease
Han, N., Kim, E. H., Choi, J. H., Lee, H., & Hahm, K. (2012) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2012.00625.x · Cited by 12
Cited by
Ungaro, R., Mehandru, S., Allen, P. B., Peyrin-Biroulet, L., & Colombel, J.-F. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32126-2 · Cited by 3,531
Turner, D., Ricciuto, A., Lewis, A., D’Amico, F., Dhaliwal, J., Griffiths, A. M., Bettenworth, D., Sandborn, W. J., Sands, B. E., Reinisch, W., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.12.031 · Cited by 2,911
Self-citationACG Clinical Guideline: Ulcerative Colitis in Adults
Rubin, D. T., Ananthakrishnan, A. N., Siegel, C. A., Sauer, B. G., & Long, M. D. (2019) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000152 · Cited by 1,577
Calprotectin: from biomarker to biological function
Jukic, A., Bakiri, L., Wagner, E. F., Tilg, H., & Adolph, T. E. (2021) · Gut · doi:10.1136/gutjnl-2021-324855 · Cited by 500
Feuerstein, J. D., Moss, A. C., & Farraye, F. A. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.01.018 · Cited by 398
Metadata
- Authors
- Sands, B. E.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 149
- Issue
- 5
- Pages
- 1275-1285.e2
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1927464939
- Cited by
- 405
- References
- 76
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.